Skip navigation
 
Valeant

ICN Pharmaceuticals engaged RBW to assist in positioning, branding and renaming ICN in a way that captured the new direction and values of the company. The change required considering legal entities, stock symbols, signage, website, collateral and packaging. Once the name was selected and cleared, the entire campaign went from concept to production within 60 days of the assignment, winning praise not only internally from Valeant, but from industry analysts as well.
Print "Parkinson's"
Case Study
Print "Letter V"
Print "Parkinson's" Print "Letter V"